Literature DB >> 8514892

Hormonal control of intestinal Fc receptor gene expression and immunoglobulin transport in suckling rats.

M G Martín1, S V Wu, J H Walsh.   

Abstract

Hormonal control of immunoglobulin (Ig) absorption and of intestinal Fc receptor mRNA expression were investigated in rats to assess its potential role in the normal postsuckling inhibition of this transport system. Corticosterone and L-thyroxine therapy caused premature inhibition of the absorption of orally administered murine monoclonal antibody and of Fc receptor mRNA expression in a dose- and time-dependent manner. Low-dose corticosterone had no effect on Fc receptor mRNA synthesis after 3 d but decreased Ig transport fivefold after 7 d. High dose corticosterone resulted in a threefold reduction in Fc receptor after 3 d, and there was almost complete inhibition (> 30-fold) of transport and of Fc receptor transcript levels after 7 d. Similarly, 7 d of high-dose thyroxine decreased both serum Ig transport and Fc receptor (> 30-fold). However, adrenalectomy did not prevent the normal post-suckling declines in Ig transport or receptor synthesis. This study demonstrates that exogenous corticosteroids and thyroxine hormone inhibit Ig transport and steady-state duodenal Fc receptor mRNA levels in suckling rats. Endogenous adrenal steroids however, do not appear to be entirely responsible for the age-dependent decline in this transport system.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8514892      PMCID: PMC443353          DOI: 10.1172/JCI116528

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  29 in total

Review 1.  The polymeric immunoglobulin receptor. A model protein to study transcytosis.

Authors:  G Apodaca; M Bomsel; J Arden; P P Breitfeld; K Tang; K E Mostov
Journal:  J Clin Invest       Date:  1991-06       Impact factor: 14.808

2.  Involvement of developing sympathetic nervous system in thyroxine-mediated submandibular gland nerve growth factor and epidermal growth factor responses.

Authors:  J Lakshmanan; J Padbury; T Macaso; D Wang; U Beri; D A Fisher
Journal:  Pediatr Res       Date:  1986-03       Impact factor: 3.756

3.  Enhanced ELISA: how to measure less than 10 picograms of a specific protein (immunoglobulin) in less than 8 hours.

Authors:  E Macy; M Kemeny; A Saxon
Journal:  FASEB J       Date:  1988-11       Impact factor: 5.191

4.  Developmental physiology. Hard-wired local triggering of intestinal enzyme expression.

Authors:  J M Diamond
Journal:  Nature       Date:  1986 Dec 4-10       Impact factor: 49.962

5.  An Fc receptor structurally related to MHC class I antigens.

Authors:  N E Simister; K E Mostov
Journal:  Nature       Date:  1989-01-12       Impact factor: 49.962

Review 6.  Ontogenesis of hypothalamic--pituitary--thyroid function and metabolism in man, sheep, and rat.

Authors:  D A Fisher; J H Dussault; J Sack; I J Chopra
Journal:  Recent Prog Horm Res       Date:  1976

7.  The effects of corticosterone and cortisone on the uptake of polyvinyl pyrrolidone and the transmission of immunoglobulin G by the small intestine in young rats.

Authors:  B Morris; R Morris
Journal:  J Physiol       Date:  1976-01       Impact factor: 5.182

8.  Thyroxine and cortisone cooperate to modulate postnatal intestinal enzyme differentiation in the rat.

Authors:  K Y Yeh; M Yeh; P R Holt
Journal:  Am J Physiol       Date:  1991-03

9.  Hormonal effects on development of the secretory apparatus of chief cells.

Authors:  C C Tseng; K L Schmidt; L R Johnson
Journal:  Am J Physiol       Date:  1987-09

10.  Intestinal transport of antibodies in the newborn rat.

Authors:  R Rodewald
Journal:  J Cell Biol       Date:  1973-07       Impact factor: 10.539

View more
  7 in total

Review 1.  How the controller is controlled - neonatal Fc receptor expression and immunoglobulin G homeostasis.

Authors:  Shuo-Wang Qiao; Wayne I Lencer; Richard S Blumberg
Journal:  Immunology       Date:  2006-11-28       Impact factor: 7.397

Review 2.  Chapter 4: Multitasking by exploitation of intracellular transport functions the many faces of FcRn.

Authors:  E Sally Ward; Raimund J Ober
Journal:  Adv Immunol       Date:  2009       Impact factor: 3.543

Review 3.  The neonatal Fc receptor as therapeutic target in IgG-mediated autoimmune diseases.

Authors:  Alina Sesarman; Gestur Vidarsson; Cassian Sitaru
Journal:  Cell Mol Life Sci       Date:  2010-03-09       Impact factor: 9.261

4.  Ontogenetic development and distribution of antibody transport and Fc receptor mRNA expression in rat intestine.

Authors:  M G Martín; S V Wu; J H Walsh
Journal:  Dig Dis Sci       Date:  1997-05       Impact factor: 3.199

5.  Randomized phase 2 study of FcRn antagonist efgartigimod in generalized myasthenia gravis.

Authors:  James F Howard; Vera Bril; Ted M Burns; Renato Mantegazza; Malgorzata Bilinska; Andrzej Szczudlik; Said Beydoun; Francisco Javier Rodriguez De Rivera Garrido; Fredrik Piehl; Mariarosa Rottoli; Philip Van Damme; Tuan Vu; Amelia Evoli; Miriam Freimer; Tahseen Mozaffar; E Sally Ward; Torsten Dreier; Peter Ulrichts; Katrien Verschueren; Antonio Guglietta; Hans de Haard; Nicolas Leupin; Jan J G M Verschuuren
Journal:  Neurology       Date:  2019-05-22       Impact factor: 9.910

6.  Feedback regulation of thyrotropin-releasing hormone gene expression by thyroid hormone in the caudal raphe nuclei in rats.

Authors:  H Yang; P Yuan; V Wu; Y Taché
Journal:  Endocrinology       Date:  1999-01       Impact factor: 4.736

Review 7.  Understanding Inter-Individual Variability in Monoclonal Antibody Disposition.

Authors:  Veena A Thomas; Joseph P Balthasar
Journal:  Antibodies (Basel)       Date:  2019-12-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.